200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 19388-87-5

19388-87-5

19388-87-5 | Taurolidin

CAS No: 19388-87-5 Catalog No: AG003UHO MDL No:MFCD00865076

Product Description

Catalog Number:
AG003UHO
Chemical Name:
Taurolidin
CAS Number:
19388-87-5
Molecular Formula:
C7H16N4O4S2
Molecular Weight:
284.3563
MDL Number:
MFCD00865076
IUPAC Name:
4-[(1,1-dioxo-1,2,4-thiadiazinan-4-yl)methyl]-1,2,4-thiadiazinane 1,1-dioxide
InChI:
InChI=1S/C7H16N4O4S2/c12-16(13)3-1-10(5-8-16)7-11-2-4-17(14,15)9-6-11/h8-9H,1-7H2
InChI Key:
AJKIRUJIDFJUKJ-UHFFFAOYSA-N
SMILES:
O=S1(=O)CCN(CN1)CN1CCS(=O)(=O)NC1
EC Number:
243-016-5
UNII:
8OBZ1M4V3V

Properties

Complexity:
419  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
284.061g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
284.349g/mol
Monoisotopic Mass:
284.061g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
116A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.7  

Literature

Title Journal
Taurolidine: mode of administration in mouse tumor models. International journal of cancer 20121201
Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock. Journal of pediatric gastroenterology and nutrition 20121001
Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20121001
Taurolidine: Mode of administration in mouse tumor models. International journal of cancer 20120915
The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. International journal of cancer 20120901
Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients. Clinical nutrition (Edinburgh, Scotland) 20120801
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. Anticancer research 20120701
Efficacy of taurolidine against periodontopathic species--an in vitro study. Clinical oral investigations 20120601
Taxol and taurine protect the renal tissue of rats after unilateral ureteral obstruction: a stereological survey. Korean journal of urology 20120501
Antibacterial effect of taurolidine (2%) on established dental plaque biofilm. Clinical oral investigations 20120401
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. The Journal of hospital infection 20120401
Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis. Seminars in dialysis 20120101
Taurolidine use as a Scolicidal Agent: We Need Different Methodologies. Turkiye parazitolojii dergisi 20120101
In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma. Toxicology in vitro : an international journal published in association with BIBRA 20111201
Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. The Korean journal of hepatology 20111201
Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery? International orthopaedics 20111101
[Tunnelled internal jugular vein catheters with taurolidine lock: an acceptable challenge to arterio-venous fistula in 70 years old haemodialyzed patients: a prospective pilot study]. Nephrologie & therapeutique 20110701
Taurolidine lock - experience from the West of Scotland. Clinical nutrition (Edinburgh, Scotland) 20110601
Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies. An update. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20110401
Advances in the diagnosis and management of central venous access device infections in children. Advances in experimental medicine and biology 20110101
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. Clinical nephrology 20110101
Animal models of bacterial keratitis. Journal of biomedicine & biotechnology 20110101
Animal models of colitis-associated carcinogenesis. Journal of biomedicine & biotechnology 20110101
Treatment of long-term catheter-related bloodstream infections with a taurolidine block: a single cancer center experience. The journal of vascular access 20110101
Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. American journal of nephrology 20110101
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. Journal of toxicology and environmental health. Part B, Critical reviews 20110101
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study. Journal of translational medicine 20110101
Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma. Ultrasound in medicine & biology 20101101
The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine. Surgery 20100901
Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clinical nutrition (Edinburgh, Scotland) 20100801
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation 20100601
The evolving role of taurolidine in cancer therapy. Annals of surgical oncology 20100401
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. International journal of colorectal disease 20100201
Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PloS one 20100101
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. Journal of experimental & clinical cancer research : CR 20100101
Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC cancer 20100101
Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice. Journal of carcinogenesis 20100101
Taurine and the renal system. Journal of biomedical science 20100101
[The protoskolicidal effect of 1% polyvinylpyrrolidone-iodine (PVP-1) and 2% taurolidine on abdominal hydatidosis]. Turkiye parazitolojii dergisi 20100101
Gene expression analysis of cell death induction by taurolidine in different malignant cell lines. BMC cancer 20100101
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma. The European respiratory journal 20091201
Taurolidine in the prevention and therapy of lung metastases. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20091201
Principles of the therapy of bone infections in adult extremities : Are there any new developments? Strategies in trauma and limb reconstruction (Online) 20091001
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo. Oncology reports 20090801
[Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection]. Zentralblatt fur Chirurgie 20090801
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090601
The antibacterial substance taurolidine exhibits anti-neoplastic action based on a mixed type of programmed cell death. Autophagy 20090201
Wound healing is not impaired in rats undergoing perioperative treatment with the antineoplastic agent taurolidine. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20090101
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial. World journal of surgical oncology 20090101
All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Molecular neurodegeneration 20090101
Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction. Journal of experimental & clinical cancer research : CR 20090101
Using detachment-promoting agents for the prevention of chronic peritoneal dialysis-associated infections. Artificial organs 20081201
Effects of topical application of taurolidine on second intention healing of experimentally induced wounds in rats. American journal of veterinary research 20080901
A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. Journal of renal care 20080901
Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. Journal of pediatric gastroenterology and nutrition 20080801
Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus. International journal of oncology 20080601
Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets. Mini reviews in medicinal chemistry 20080501
Re: Endophthalmitis: a review of current evaluation and management. Retina (Philadelphia, Pa.) 20080201
The effect of taurolidine on experimental thrombus formation. European journal of pharmacology 20080114
An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis. The Journal of surgical research 20080101
Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20080101
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC infectious diseases 20080101
TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. Journal of experimental & clinical cancer research : CR 20080101
The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model. The Journal of surgical research 20071201
Intra-abdominal use of taurolidine or heparin as alternative products to an antiadhesive barrier (Seprafilm) in adhesion prevention: an experimental study on mice. Diseases of the colon and rectum 20071201
Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins. Journal of surgical oncology 20070901
Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines. Investigational new drugs 20070801
Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia. International journal of colorectal disease 20070701
Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma. Lung cancer (Amsterdam, Netherlands) 20070601
The pharmacokinetics of taurolidine metabolites in healthy volunteers. Journal of clinical pharmacology 20070601
Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20070501
Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy. The Journal of surgical research 20070101
Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20070101
Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients. Clinical pharmacokinetics 20070101
Is Taurolidine a candidate for treatment of rheumatoid arthritis? Clinical and experimental rheumatology 20070101
Treatment of multiple liver metastasis from gastric carcinoma. World journal of surgical oncology 20070101
Noninvasive monitoring of myocardial function after surgical and cytostatic therapy in a peritoneal metastasis rat model: assessment with tissue Doppler and non-Doppler 2D strain echocardiography. Cardiovascular ultrasound 20070101
Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20070101
Oral administration of taurolidine ameliorates chronic DSS colitis in mice. Journal of investigative surgery : the official journal of the Academy of Surgical Research 20070101
Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells. Journal of investigative surgery : the official journal of the Academy of Surgical Research 20070101
Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060701
Co-immunotherapy with interleukin-2 and taurolidine for progressive metastatic melanoma. Irish journal of medical science 20060101
Effect of peritoneal lavage with taurolidine on primary colonic anastomosis in a rat model of secondary peritonitis. Surgery today 20060101
Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case. World journal of surgical oncology 20060101
Hyaluronic acid/carboxymethylcellulose membrane barrier versus taurolidine for the prevention of adhesions to polypropylene mesh. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101
Catheter lock solutions: it's time for a change. The journal of vascular access 20060101
Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. Advances in experimental medicine and biology 20060101
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats. The Journal of surgical research 20051101
[Diagnostics and management of central venous line infections in pediatric cancer patients]. Klinische Padiatrie 20051101
Taurolidine--a new drug with anti-tumor and anti-angiogenic effects. Anti-cancer drugs 20051001
Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clinical nutrition (Edinburgh, Scotland) 20050601
Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. Pediatric surgery international 20050601
Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine. Journal of neurosurgery 20050601
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer. Investigational new drugs 20050301
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model. Current eye research 20050301
Comment on 'in vivo effects of fluoroquinolones on rabbit corneas'. Clinical & experimental ophthalmology 20050201
Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. Surgical endoscopy 20050201
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats. Clinical & experimental metastasis 20050101
The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research 20041115
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. International journal of cancer 20041101
Dialysis catheter-related bacteremia: treatment and prophylaxis. American journal of kidney diseases : the official journal of the National Kidney Foundation 20041101
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. International journal of antimicrobial agents 20041101
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer. Cancer chemotherapy and pharmacology 20040901
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601
Irrigation of port sites: prevention of port site metastases? Journal of laparoendoscopic & advanced surgical techniques. Part A 20040601
Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits. Current eye research 20040401
Treatment of glioblastoma with intravenous taurolidine. First clinical experience. Anticancer research 20040101
Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors. Anticancer research 20040101
Challenges in ocular infectious diseases and the evolution of anti-infective therapy. Survey of ophthalmology 20040101
Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer. Prostaglandins, leukotrienes, and essential fatty acids 20031001
Taurine: new implications for an old amino acid. FEMS microbiology letters 20030926
The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model. Surgical endoscopy 20030701
Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030615
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. The Journal of antimicrobial chemotherapy 20030401
The effect of Taurolidine on adherent and floating subpopulations of melanoma cells. Anti-cancer drugs 20030401
[In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity]. Mund-, Kiefer- und Gesichtschirurgie : MKG 20030301
Enhancement of Fas-ligand-mediated programmed cell death by taurolidine. Anticancer research 20030101
Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy. Clinical & experimental metastasis 20030101
Novel therapies for sepsis: antiendotoxin therapies. Expert opinion on investigational drugs 20021201
Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection. The British journal of surgery 20021101
Activity of disinfectants against Gram-negative bacilli isolated from patients undergoing lung transplantation for cystic fibrosis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20021101
Taurolidine attenuates the hemodynamic and respiratory changes associated with endotoxemia. Shock (Augusta, Ga.) 20020401
Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging. Bone marrow transplantation 20020201
Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock. Blood purification 20020101
Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer. Clinical & experimental metastasis 20020101
A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 20020101
The effect of taurolidine on brain tumor cells. Anticancer research 20020101
The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism. Anticancer research 20020101
Influence of antiseptic agents on interleukin-8 release and transmigration of polymorphonuclear neutrophils in a human in vitro model of peritonitis. Surgical infections 20020101
Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. The Journal of surgical research 20011201
Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer research 20010915
[Experimental study of antiseptic (tauroline, taurolidine) and antibiotic (sulmycin implant) drugs in vascular prosthesis infections in a standardized infection model]. Zentralblatt fur Chirurgie 20010501
Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood purification 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.